SCHEMBL19631422

SCHEMBL19631422

CC(C)OC(=O)c1ccccc1/C=N/N(C)c1nc(-c2ccccc2Cl)cs1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
▸ DHODH Q02127 20/20 1.00

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30131128 1.00 DHODH (1.00) DHODH
SCHEMBL30131131 0.91 DHODH (0.84) DHODH
SCHEMBL19631435 0.91 DHODH (0.84) DHODH
SCHEMBL19631395 0.91 DHODH (0.82) DHODH
SCHEMBL20842825 0.90 DHODH (0.82) DHODH
SCHEMBL30131120 0.88 DHODH (1.00) DHODH
SCHEMBL19631433 0.88 DHODH (1.00) DHODH
SCHEMBL28975801 0.87 DHODH (0.81) DHODH
SCHEMBL28975796 0.87 DHODH (0.81) DHODH
SCHEMBL20836131 0.86 DHODH (1.00) DHODH

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11534427-B2 Applications of novel thiazole derivative in treating inflammatory bowel diseases EAST CHINA UNIVERSITY OF SCIENCE AND TECHNOLOGY (CN) 2022-12-27 — — US disclosed
EP-3459937-B1 THIAZOLE DERIVATIVE AND APPLICATIONS UNIV EAST CHINA SCIENCE & TECH (CN) 2021-12-29 — — EP disclosed
US-10919869-B2 Thiazole derivative and applications EAST CHINA UNIVERSITY OF SCIENCE AND TECHNOLOGY (CN) 2021-02-16 — — US disclosed
US-20190290620-A1 APPLICATIONS OF NOVEL THIAZOLE DERIVATIVE IN TREATING INFLAMMATORY BOWEL DISEASES EAST CHINA UNIVERSITY OF SCIENCE AND TECHNOLOGY (CN) 2019-09-26 — — US disclosed
US-20190292162-A1 THIAZOLE DERIVATIVE AND APPLICATIONS EAST CHINA UNIVERSITY OF SCIENCE AND TECHNOLOGY (CN) 2019-09-26 — — US disclosed
EP-3459937-A1 THIAZOLE DERIVATIVE AND APPLICATIONS East China University of Science and Technology (CN) 2019-03-27 — — EP disclosed
WO-2017198179-A1 APPLICATIONS OF NOVEL THIAZOLE DERIVATIVE IN TREATING INFLAMMATORY BOWEL DISEASES 华东理工大学 2017-11-23 — — WO disclosed
WO-2017198178-A1 THIAZOLE DERIVATIVE AND APPLICATIONS 华东理工大学 2017-11-23 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11534427-B2 Applications of novel thiazole derivative in treating inflammatory bowel diseases FABP2, SLC10A2, ALPI DHODH 803/4885
US-20190292162-A1 THIAZOLE DERIVATIVE AND APPLICATIONS DHODH, DLD, THOC2 DHODH 1/4885
US-20190290620-A1 APPLICATIONS OF NOVEL THIAZOLE DERIVATIVE IN TREATING INFLAMMATORY BOWEL DISEASES FABP2, SLC10A2, ALPI DHODH 803/4885
US-10919869-B2 Thiazole derivative and applications DHODH, DLD, THOC2 DHODH 1/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback